Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index.

Raslová, Katarina; Tamer, Soren Can; Clauson, Per; Karl, Diane

Raslová, Katarina; Tamer, Soren Can; Clauson, Per; Karl, Diane.

Affiliation

Raslová K; Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic. katarina.raslova@nextra.sk

Clin Drug Investig ; 27(4): 279-85, 2007.

Article in En | MEDLINE | ID: mdl-17358100

Subject(s)

Body Mass Index; Diabetes Mellitus, Type 2/drug therapy; Insulin/analogs & derivatives; Weight Gain/drug effects; Aged; Diabetes Mellitus, Type 2/physiopathology; Double-Blind Method; Female; Humans; Insulin/pharmacology; Insulin/therapeutic use; Insulin Detemir; Insulin, Long-Acting; Male; Middle Aged

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Weight Gain / Body Mass Index / Diabetes Mellitus, Type 2 / Insulin Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links